Aimmune Therapeutics Inc Stock Price (AIMT)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q3 2020 Results - Earnings Call TranscriptWed, 28 Oct 2020 15:36:12 UTC via Seeking Alpha
Is Principal’s BTEC the Healthcare ETF to Hold Come Election Day?Tue, 27 Oct 2020 10:25:08 UTC via ETF Trends
C4 Therapeutics started at outperform with $33 stock price target at BMO CapitalTue, 27 Oct 2020 08:29:04 UTC via MarketWatch
3M profit beats estimates on healthcare product boostTue, 27 Oct 2020 06:49:03 UTC via Yahoo Finance
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)Mon, 26 Oct 2020 23:54:35 UTC via Yahoo Finance
Sage Therapeutics May Have The Juice That's Worth The Speculative SqueezeMon, 26 Oct 2020 10:04:56 UTC via Seeking Alpha
Medical Office Buildings, 5% Yield, 8% 2020 Growth: Healthcare Trust Of AmericaMon, 26 Oct 2020 09:15:00 UTC via Seeking Alpha
Barron's Picks And Pans: Coca-Cola, Sprouts Farmers Market, Mirati Therapeutics And MoreSun, 25 Oct 2020 09:21:18 UTC via Yahoo Finance
Is Sarepta Therapeutics (NASDAQ:SRPT) Weighed On By Its Debt Load?Fri, 23 Oct 2020 12:56:32 UTC via Yahoo Finance
6%-7% Yields, 10%-16% Discounts: Tekla Healthcare Opportunities, Gabelli Healthcare & Wellness TrustFri, 23 Oct 2020 09:15:00 UTC via Seeking Alpha

Aimmune Therapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AIMT

You don't have any alerts set for IEX:AIMT.

About Aimmune Therapeutics Inc

Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.

CEOJayson Donald Alexander Dallas IndustryBiotechnology SectorHealthcare Websitehttps://www.aimmune.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time AIMT to USD Trade Analysis on IEX

Market Status Premarket

Analysis is available when the exchange & market are open.